"The Push for Modern Manufacturing," an expert view on how to respond to FDA's Process Analytical Technology initiative, by Tunnell Consultants Philippe Cini and Raymond Schneider, was published in the March 2004 issue of Pharmaceutical Executive. This article answers questions such as: Will PAT slow my regulatory processes? Will PAT reveal hidden problems I can't manage? Will PAT push my costs out-of-control? Will PAT bury us in data? To learn about the Tunnell strategy in detail, and how you can apply a PAT approach that fully satisfies the FDA without causing major company disruption -- please click here to download the full article.